Non-Performing Assets / Total Loans: A classification used by financial institutions that refer to loans that are in jeopardy of default as a potion of total loans made. Calculated as: Non-Perfroming Assets / Gross Loans Made
Rocket Pharmaceuticals, Inc. (RCKT) Non-Performing Assets / Total Loans data is not available.
| Income Statement Financials | |
-- |
|
$-50.33M |
|
-- |
|
-- |
|
$52.25M |
|
$-52.25M |
|
$1.92M |
|
$-50.33M |
|
$-50.33M |
|
$-50.33M |
|
$-50.33M |
|
$-50.33M |
|
$-50.33M |
|
$-52.25M |
|
$-49.01M |
|
111.57M |
|
111.57M |
|
$-0.45 |
|
$-0.45 |
|
| Balance Sheet Financials | |
$227.68M |
|
$29.77M |
|
$140.35M |
|
$368.03M |
|
$31.17M |
|
$19.38M |
|
$23.19M |
|
$54.36M |
|
$313.67M |
|
$249.37M |
|
$313.67M |
|
108.21M |
|
| Cash Flow Statement Financials | |
$-155.17M |
|
$67.34M |
|
$0.15M |
|
$165.00M |
|
$77.31M |
|
$-87.68M |
|
$30.95M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
7.30 |
|
|
Non-Performing Assets / Total Loans |
-- |
-- |
|
0.06 |
|
0.07 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-155.53M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-16.05% |
|
-20.18% |
|
-13.68% |
|
-15.11% |
|
$2.90 |
|
$-1.39 |
|
$-1.39 |
|